ETHK Labs Delays Key Circular on Major Share Acquisition and Voting Rights Deal

IVD Medical Holding Limited ( (HK:1931) ) has issued an update.

ETHK Labs Inc. has announced a delay in sending to shareholders a circular related to a major transaction involving the acquisition of shares in a target company and associated voting rights entrustment arrangements. The circular, which will include details of the share transfer and voting rights agreements, financial information of the target group and notice of an extraordinary general meeting, is now expected to be dispatched on or before 29 May 2026 instead of the previously indicated date of 17 April 2026.

The postponement reflects the additional time required to finalize financial and other key information on the target group, underscoring the complexity and significance of the proposed deal for ETHK Labs’ governance and future strategic direction. While the delay may slightly extend the transaction timetable, it also signals an effort to provide shareholders with more complete disclosure ahead of voting, which could influence investor confidence and the company’s positioning within its sector once the acquisition progresses.

More about IVD Medical Holding Limited

ETHK Labs Inc., formerly known as IVD Medical Holding Limited, is a Cayman Islands-incorporated company listed in Hong Kong under stock code 1931. The group operates in the medical and diagnostics space, and its current strategic focus includes expanding control over a target group through a planned acquisition of shares combined with an entrustment of voting rights.

Average Trading Volume: 3,984,833

Technical Sentiment Signal: Sell

Current Market Cap: HK$1.7B

See more data about 1931 stock on TipRanks’ Stock Analysis page.